玻璃体出血是眼部常见的并发症,且予后不佳,致盲率甚高;以往全身给药均未能收到满意效果。我于1987年1月至1988年1月对玻璃体出血试用球结膜下注射尿激酶治疗,现将体会报告如下:临床资料接受治疗病人共16侧,男性9例,女性7例,年令最大56岁,年令最小24岁,平均 Vitreous hemorrhage is a common complication of the eye, and poor prognosis, blindness rate is very high; in the past systemic administration failed to receive satisfactory results. I January 1987 to January 1988 trial of vitreous hemorrhage subconjunctival injection of urokinase, the experience will be reported as follows: The clinical data of patients treated a total of 16 sides, 9 males and 7 females, the largest number of 56 Years old, the youngest 24 years old, on average